EUVIMEDEUVIMED entdecken
Crossref

Enterolactone mitigates atherosclerosis by facilitating resolution of ferroptosis-associated intimal inflammation via the Keap1/Nrf2/GPX4 pathway

Shuhui Chai, Yihang Zhang, Yi Guo, Danli Cao, Jiaxing Wang, Yu Yan, Yuxue Shi, Zhiyi Yuan, Xiaoyu Wang, Tingting Tong, Ziyi Zhen, Yanhao Huo und 8 weitere

Phytomedicine · 2026-06 · 155 · 158178

DOI: 10.1016/j.phymed.2026.158178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026-06. Verfasst von Shuhui Chai und 19 weiteren Autor:innen. Beteiligte Einrichtung: Genomics Research Center (Key Laboratory of Gut Microbiota and Pharmacogenomics of Heilongjiang Province, State-Province Key Laboratory of Biomedicin…. Hauptthemen laut MEDLINE: Lignans, Atherosclerosis, Kelch-Like ECH-Associated Protein 1, 4-Butyrolactone. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Harbin Medical University, Natural Science Foundation of Heilongjiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Atherosclerosis is the inflammatory consequence of lipid accumulation with plaque formation in the vascular intima and is a common condition to develop into various cardiovascular diseases. Current therapies do not always lead to satisfactory treatment outcomes. Enterolactone, a mammalian lignan produced by bacterial transformation from plant lignans, has a preventive effect against cardiovascular disease. However, its effect on atherosclerosis and the underlying mechanism of action remain unclear. PURPOSE: To explore the therapeutic effect of ENL on atherosclerosis and elucidate the underlying mechanism. METHODS: We established a model of atherosclerosis on ApoE-/- C57BL/6 mice by high fat diet. The aortic root was collected and sectioned to assess arterial plaque area, collagen fibrillar proliferation, and lipid content. RT-qPCR was used to determine the inflammatory response in the artery of mice. The serum from mice was isolated to measure lipid levels, and the fecal microbiota was analyzed by 16S rDNA. H2O2 was used to induce HUVEC injury and ferroptosis to mimic endothelial cell dysfunction in atherosclerosis, and the inhibitory effect of ENL on HUVEC ferroptosis was appraised by monitoring ferroptosis indexes and levels of iron-related proteins. RESULTS: In the animals, enterolactone significantly improved lipid metabolism, attenuated ferroptosis occurring in the intima, facilitated the antioxidant mechanisms, and promoted healing of the endothelial lesions, by interacting with Nrf2. Of great importance, enterolactone massively altered the gut microbiota toward a curative outcome by elevating the abundance of beneficial bacteria, such as the SCFA-producing taxa. Additionally, ENL suppresses lipid peroxidation and inflammatory activation in HUVECs by regulating the Keap1/Nrf2/GPX4 pathway, and knocking down Nrf2 attenuates the treatment effect of ENL. CONCLUSION: Enterolactone effectively resolves intimal inflammation and redresses atherosclerosis by ameliorating the gut microbiome and modulating lipid metabolism via the Keap1/Nrf2/GPX4 pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LignansAtherosclerosisKelch-Like ECH-Associated Protein 14-ButyrolactoneFerroptosisAnimalsNF-E2-Related Factor 2Mice, Inbred C57BLHumansMiceInflammationMaleGastrointestinal MicrobiomeSignal TransductionDiet, High-FatHuman Umbilical Vein Endothelial CellsDisease Models, Animal

Stichwörter der Autor:innen

AtherosclerosisEnterolactoneFerroptosisGut microbiomeNrf2

Substanzen

LignansNF-E2-Related Factor 2Kelch-Like ECH-Associated Protein 14-Butyrolactone2,3-bis(3'-hydroxybenzyl)butyrolactoneNfe2l2 protein, mouseKeap1 protein, mouse

Autor:innen und Institutionen

  • Genomics Research Center (Key Laboratory of Gut Microbiota and Pharmacogenomics of Heilongjiang Province, State-Province Key Laboratory of Biomedicine-Pharmaceutics of China), College of Pharmacy, Harbin Medical Univers…
  • Department of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
  • State Key Laboratory of Frigid Zone Cardiovascular Diseases, Harbin 150081, China; Department of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China. Electronic address: bantao2000@163.com.

Förderung

  • National Natural Science Foundation of China
  • Harbin Medical University
  • Natural Science Foundation of Heilongjiang Province
  • China Postdoctoral Science Foundation

Zitieren

APA

Chai, S., Zhang, Y., Guo, Y., Cao, D., Wang, J., Yan, Y., Shi, Y., Yuan, Z., Wang, X., Tong, T., Zhen, Z., Huo, Y., Zhang, K., Wang, F., Liu, G. R., Li, W., Xu, X., Ban, T., Liu, S. L., & Liu, H. (2026). Enterolactone mitigates atherosclerosis by facilitating resolution of ferroptosis-associated intimal inflammation via the Keap1/Nrf2/GPX4 pathway. Phytomedicine, 155, 158178. https://doi.org/10.1016/j.phymed.2026.158178

Vancouver

Chai S, Zhang Y, Guo Y, Cao D, Wang J, Yan Y, et al. Enterolactone mitigates atherosclerosis by facilitating resolution of ferroptosis-associated intimal inflammation via the Keap1/Nrf2/GPX4 pathway. Phytomedicine. 2026;155:158178. doi:10.1016/j.phymed.2026.158178

BibTeX
@article{Chai2026,
  author = {Chai, Shuhui and Zhang, Yihang and Guo, Yi and Cao, Danli and Wang, Jiaxing and Yan, Yu and Shi, Yuxue and Yuan, Zhiyi and Wang, Xiaoyu and Tong, Tingting and Zhen, Ziyi and Huo, Yanhao and Zhang, Kaiwen and Wang, Fenglin and Liu, Gui-Rong and Li, Weiheng and Xu, Xiaohui and Ban, Tao and Liu, Shu-Lin and Liu, Huidi},
  title = {Enterolactone mitigates atherosclerosis by facilitating resolution of ferroptosis-associated intimal inflammation via the Keap1/Nrf2/GPX4 pathway},
  journal = {Phytomedicine},
  year = {2026},
  volume = {155},
  pages = {158178},
  doi = {10.1016/j.phymed.2026.158178}
}
Kostenlos starten →